Description: Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari is focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.
Home Page: www.inarimedical.com
NARI Technical Analysis
6001 Oak Canyon
Irvine,
CA
92618
United States
Phone:
877 923 4747
Officers
| Name | Title |
|---|---|
| Mr. William H. Hoffman | CEO, Pres & Director |
| Mr. Mitchell C. Hill | Chief Financial Officer |
| Mr. Andrew J. Hykes | Chief Operating Officer |
| Dr. Thomas M. Tu M.D. | Chief Medical Officer |
| Ms. Janet Byk | VP of Fin. & Accounting |
| Ms. Angela Ahmad | Gen. Counsel & Sec. |
| Mr. Eric Khairy | Sr. VP of Marketing |
| Mr. John R. Borrell | Sr. VP of Sales |
| Ms. Dena Truelove | VP of HR |
| Ms. Tara Dunn | Sr. VP of Clinical Affairs & Market Devel. |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 1428.5714 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 8.943 |
| Price-to-Sales TTM: | 9.8391 |
| IPO Date: | 2020-05-22 |
| Fiscal Year End: | December |
| Full Time Employees: | 800 |